# Wide Range Applications of Spirulina: From Earth to Space Missions

**Authors:** Giacomo Fais, Alessia Manca, Federico Bolognesi, Massimiliano Borselli, Alessandro Concas, Marco Busutti, Giovanni Broggi, Pierdanilo Sanna, Yandy Marx Castillo-Aleman, René Antonio Rivero-Jiménez, Antonio Alfonso Bencomo-Hernandez, Yendry Ventura-Carmenate, Michela Altea, Antonella Pantaleo, Gilberto Gabrielli, Federico Biglioli, Giacomo Cao, Giuseppe Giannaccare

PMC · DOI: 10.3390/md20050299 · Marine Drugs · 2022-04-28

## TL;DR

Spirulina, a type of cyanobacterium, shows promise for improving health in space missions and on Earth due to its diverse medical and nutritional benefits.

## Contribution

The paper highlights Spirulina's novel potential in space healthcare and its emerging roles in treating diseases like cancer and infections.

## Key findings

- Spirulina can support long-duration space missions by sustaining astronauts' health under stress.
- Spirulina improves stem cell mobility and immune response, offering new treatment possibilities in oncology and infectious diseases.
- It has applications in various medical fields, including metabolism, ophthalmology, and nephrology.

## Abstract

Spirulina is the most studied cyanobacterium species for both pharmacological applications and the food industry. The aim of the present review is to summarize the potential benefits of the use of Spirulina for improving healthcare both in space and on Earth. Regarding the first field of application, Spirulina could represent a new technology for the sustainment of long-duration manned missions to planets beyond the Lower Earth Orbit (e.g., Mars); furthermore, it could help astronauts stay healthy while exposed to a variety of stress factors that can have negative consequences even after years. As far as the second field of application, Spirulina could have an active role in various aspects of medicine, such as metabolism, oncology, ophthalmology, central and peripheral nervous systems, and nephrology. The recent findings of the capacity of Spirulina to improve stem cells mobility and to increase immune response have opened new intriguing scenarios in oncological and infectious diseases, respectively.

## Linked entities

- **Diseases:** cancer (MONDO:0004992)
- **Species:** Spirulina (taxon 1154)

## Full-text entities

- **Genes:** APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, IFI27 (interferon alpha inducible protein 27) [NCBI Gene 3429] {aka FAM14D, ISG12, ISG12A, P27}, S (surface glycoprotein) [NCBI Gene 43740568] {aka spike glycoprotein}, CDK2 (cyclin dependent kinase 2) [NCBI Gene 1017] {aka CDKN2, p33(CDK2)}, CDKN1A (cyclin dependent kinase inhibitor 1A) [NCBI Gene 1026] {aka CAP20, CDKN1, CIP1, MDA-6, P21, SDI1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, PTGS2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 5743] {aka COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2}, CD34 (CD34 molecule) [NCBI Gene 947], AFP (alpha fetoprotein) [NCBI Gene 174] {aka AFPD, FETA, HPAFP}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, CAT (catalase) [NCBI Gene 847], CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, Ncam1 (neural cell adhesion molecule 1) [NCBI Gene 17967] {aka CD56, E-NCAM, NCAM-1, Ncam}, IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, Nos2 (nitric oxide synthase 2, inducible) [NCBI Gene 18126] {aka MAC-NOS, NOS-II, Nos-2, Nos2a, i-NOS, iNOS}, PROM1 (prominin 1) [NCBI Gene 8842] {aka AC133, CD133, CORD12, MCDR2, MSTP061, PROML1}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, ASRGL1 (asparaginase and isoaspartyl peptidase 1) [NCBI Gene 80150] {aka ALP, ALP1, CRASH}, CCND1 (cyclin D1) [NCBI Gene 595] {aka BCL1, D11S287E, PRAD1, U21B31}, ACE2 (angiotensin converting enzyme 2) [NCBI Gene 59272] {aka ACEH}, AP2B1 (adaptor related protein complex 2 subunit beta 1) [NCBI Gene 163] {aka ADTB2, AP105B, AP2-BETA, CLAPB1}
- **Diseases:** Nausea (MESH:D009325), heart failure (MESH:D006333), central nervous system injury (MESH:D002493), liver (MESH:D017093), acute tubular necrosis (MESH:D007683), retinal pigment epithelium (MESH:C536309), infectious diseases (MESH:D003141), dysbiosis (MESH:D064806), kidney stones (MESH:D007669), lung metastases (MESH:D009362), Immune dysregulation (OMIM:614878), PNM (MESH:D044342), vision loss (MESH:D014786), Corneal Inflammation (MESH:D007249), disorder (MESH:D009358), tissue diseases (MESH:D003240), allergic rhinitis (MESH:D065631), tumor suppressor protein (OMIM:601308), atherogenesis (MESH:D050197), insulin resistance (MESH:D007333), demyelination (MESH:D003711), respiratory tract disease (MESH:D012140), neuropsychiatric disorders (MESH:D001523), AMD (MESH:D008268), nasal discharge (MESH:D019522), Breast Cancer (MESH:D001943), corneal diseases (MESH:D003316), retinal degeneration (MESH:D012162), memory loss (MESH:D008569), degeneration of renal tubules (MESH:D007673), Herpesvirus infection (MESH:D006566), respiratory symptoms (MESH:D012818), neurotoxic (MESH:D020258), muscle strength (MESH:D019042), cancer (MESH:D009369), viral diseases (MESH:D014777), autoimmune encephalomyelitis (MESH:D004681), burn (MESH:D002056), non-small-cell lung carcinoma (MESH:D002289), edema (MESH:D004487), Parkinson's (MESH:D010300), optic disc edema (MESH:D010211), type 1 diabetic (MESH:D003922), mitochondrial damage (MESH:D028361), 2019 coronavirus disease (MESH:D000086382), vascular dysfunction (MESH:D002561), mental fatigue (MESH:D005222), neurodegenerative diseases (MESH:D019636), dysmetabolic diseases (MESH:D024821), psychocognitive diseases (MESH:D004194), oncological (MESH:D000072716), cataracts (MESH:D002386), brain disorders (MESH:D001927), diarrhea (MESH:D003967), gastrointestinal diseases (MESH:D005767), carcinogenic (MESH:D011230), mitochondrial dysregulation (MESH:D021081), IBD (MESH:D015212), hyper- and hypoxia (MESH:D000860), infection (MESH:D007239)
- **Species:** Staphylococcus aureus (species) [taxon 1280], Measles morbillivirus (no rank) [taxon 11234], Vesicular stomatitis virus (species) [taxon 11276], Escherichia coli (E. coli, species) [taxon 562], Streptococcus thermophilus (species) [taxon 1308], Cyanobacteriota (blue-green algae, phylum) [taxon 1117], Lactobacillus sp. (species) [taxon 1591], Anabaena cylindrica (species) [taxon 1165], Spirulina (suborder) [taxon 551299], Chlorella vulgaris (species) [taxon 3077], Rattus norvegicus (brown rat, species) [taxon 10116], Lactobacillus acidophilus (species) [taxon 1579], Klebsiella pneumoniae (species) [taxon 573], Eubacterium sp. (species) [taxon 142586], Human immunodeficiency virus 1 (no rank) [taxon 11676], Homo sapiens (human, species) [taxon 9606], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Chroococcidiopsis sp. CCMEE 29 (species) [taxon 155894], Proteus vulgaris (species) [taxon 585], Anabaena sp. (species) [taxon 1167], Human alphaherpesvirus 1 (Herpes simplex virus type 1, no rank) [taxon 10298], Chromohalobacter sp. SB3 (species) [taxon 549827], Phormidium sp. OU_10 (species) [taxon 652970], uncultured cyanobacterium (species) [taxon 1211], Pseudomonas aeruginosa (species) [taxon 287], Human alphaherpesvirus 2 (no rank) [taxon 10310], Canis lupus familiaris (dog, subspecies) [taxon 9615], Bacillus subtilis (species) [taxon 1423], Limnospira maxima (species) [taxon 129910], Lacticaseibacillus casei (species) [taxon 1582], Lactobacillus delbrueckii subsp. bulgaricus (subspecies) [taxon 1585], Mus musculus (house mouse, species) [taxon 10090], Suid alphaherpesvirus 1 (no rank) [taxon 10345], Bacillus pumilus (species) [taxon 1408], Poliovirus 1 (no rank) [taxon 12080], Lactococcus lactis (species) [taxon 1358], Limnospira platensis (species) [taxon 118562], Saprolegnia sp. SPE (species) [taxon 683829], Salmonella enterica subsp. enterica serovar Typhimurium (no rank) [taxon 90371], Leptolyngbya sp. OU_13 (species) [taxon 652966], Human betaherpesvirus 5 (no rank) [taxon 10359], PX clade (clade) [taxon 569578], Adenoviridae (family) [taxon 10508]
- **Cell lines:** MDA-MB-231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062), PC3 — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_0035), H460 — Homo sapiens (Human), Lung large cell carcinoma, Cancer cell line (CVCL_0459), RPE — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_IQ82), Hep-G2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027), A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), PC7983 — Homo sapiens (Human), Pancreatic carcinoma, Cancer cell line (CVCL_UU13), 4T1 — Mus musculus (Mouse), Malignant neoplasms of the mouse mammary gland, Cancer cell line (CVCL_0125)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC9143897/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC9143897/full.md

## References

222 references — full list in the complete paper: https://tomesphere.com/paper/PMC9143897/full.md

---
Source: https://tomesphere.com/paper/PMC9143897